LH vs. DGX
Compare and contrast key facts about Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LH or DGX.
Correlation
The correlation between LH and DGX is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LH vs. DGX - Performance Comparison
Loading data...
Key characteristics
LH:
0.70
DGX:
1.28
LH:
1.29
DGX:
2.05
LH:
1.16
DGX:
1.25
LH:
0.70
DGX:
1.69
LH:
3.13
DGX:
7.60
LH:
5.93%
DGX:
3.67%
LH:
24.32%
DGX:
21.95%
LH:
-96.05%
DGX:
-49.46%
LH:
-5.27%
DGX:
-1.17%
Fundamentals
LH:
$20.29B
DGX:
$19.25B
LH:
$8.68
DGX:
$7.90
LH:
27.92
DGX:
21.83
LH:
0.92
DGX:
1.55
LH:
1.54
DGX:
1.90
LH:
2.44
DGX:
2.81
LH:
$13.18B
DGX:
$10.16B
LH:
$3.61B
DGX:
$3.31B
LH:
$1.80B
DGX:
$1.95B
Returns By Period
In the year-to-date period, LH achieves a 7.70% return, which is significantly lower than DGX's 18.08% return. Over the past 10 years, LH has underperformed DGX with an annualized return of 9.65%, while DGX has yielded a comparatively higher 11.58% annualized return.
LH
7.70%
8.96%
4.00%
16.98%
12.24%
9.65%
DGX
18.08%
5.49%
13.58%
27.85%
12.03%
11.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LH vs. DGX — Risk-Adjusted Performance Rank
LH
DGX
LH vs. DGX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LH vs. DGX - Dividend Comparison
LH's dividend yield for the trailing twelve months is around 1.17%, less than DGX's 1.73% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LH Laboratory Corporation of America Holdings | 1.17% | 1.26% | 1.18% | 0.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DGX Quest Diagnostics Incorporated | 1.73% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
Drawdowns
LH vs. DGX - Drawdown Comparison
The maximum LH drawdown since its inception was -96.05%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for LH and DGX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
LH vs. DGX - Volatility Comparison
Laboratory Corporation of America Holdings (LH) has a higher volatility of 9.22% compared to Quest Diagnostics Incorporated (DGX) at 8.09%. This indicates that LH's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LH vs. DGX - Financials Comparison
This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LH vs. DGX - Profitability Comparison
LH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported a gross profit of 948.00M and revenue of 3.35B. Therefore, the gross margin over that period was 28.3%.
DGX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported a gross profit of 863.00M and revenue of 2.65B. Therefore, the gross margin over that period was 32.5%.
LH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported an operating income of 326.00M and revenue of 3.35B, resulting in an operating margin of 9.8%.
DGX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported an operating income of 346.00M and revenue of 2.65B, resulting in an operating margin of 13.1%.
LH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported a net income of 212.80M and revenue of 3.35B, resulting in a net margin of 6.4%.
DGX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Quest Diagnostics Incorporated reported a net income of 220.00M and revenue of 2.65B, resulting in a net margin of 8.3%.